How Real-World Data Can Rescue Clinical Trials and Save Lives
David Putrino, PT, PhD - Director, Abilities Research Center; Assistant Professor, Rehabilitation and Human Performance, Icahn School of Medicine, Mount Sinai Sadiqa Mahmood, DDS, MPH - Senior Vice President of Medical Affairs, Health Catalyst Wasim Malik, PhD - Managing Partner, Iaso Ventures; Director, Massachusetts General Hospital, Harvard Medical School Elia Stupka, PhD - Senior Vice President and General Manager, Life Sciences, Health Catalyst Every year clinical trials of vital therapies are canceled, not because the therapy isn’t promising but because of issues with trial feasibility or cost. This hurts all stakeholders: patients, healthcare providers, and pharmaceutical companies. Making trials more cost-effective and feasible means improving the way participants are identified and enrolled while also cutting the time and labor of collecting data. Many researchers say real-world evidence in the form of multiple-source enterprise data warehouse (EDW) data is the answer, but this requires bridging some gaps in interoperability and security. Learn from panel experts who work in all facets of clinical trials in this discussion about the promises and challenges of integrating EDW data into clinical trials.